Mayne Pharma Group Limited (MAYNF)
MAYNF Stock Price Chart
Explore Mayne Pharma Group Limited interactive price chart. Choose custom timeframes to analyze MAYNF price movements and trends.
MAYNF Company Profile
Discover essential business fundamentals and corporate details for Mayne Pharma Group Limited (MAYNF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
22 Mar 2013
Employees
450.00
Website
https://www.maynepharma.comCEO
Shawn Patrick O'Brien
Description
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
MAYNF Financial Timeline
Browse a chronological timeline of Mayne Pharma Group Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Feb 2026
Earnings released on 20 Aug 2025
Earnings released on 24 Feb 2025
EPS came in at -$0.16 falling short of the estimated -$0.08 by -102.41%, while revenue for the quarter reached $131.81M , beating expectations by +7.33%.
Earnings released on 22 Aug 2024
EPS came in at -$0.88 falling short of the estimated -$0.15 by -489.54%, while revenue for the quarter reached $133.67M , missing expectations by -0.73%.
Earnings released on 13 May 2024
EPS came in at -$0.59 falling short of the estimated -$0.31 by -88.79%, while revenue for the quarter reached $127.94M , beating expectations by +16.73%.
Earnings released on 30 Jun 2023
EPS came in at -$1.37 falling short of the estimated -$0.38 by -260.36%, while revenue for the quarter reached $54.74M , missing expectations by -52.49%.
Stock split effective on 23 Jan 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 18 Jan 2023
A dividend of $0.02 per share was announced, adjusted to $0.38. The dividend was paid on 27 Jan 2023.
Stock split effective on 18 Jan 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Dec 2022
EPS came in at -$1.12 falling short of the estimated -$0.55 by -103.17%, while revenue for the quarter reached $69.14M , beating expectations by +27.31%.
Earnings released on 30 Jun 2022
EPS came in at -$1.66 falling short of the estimated -$0.13 by -1.14K%, while revenue for the quarter reached $157.01M , beating expectations by +1.72%.
Earnings released on 30 Dec 2021
EPS came in at -$0.45 falling short of the estimated -$0.08 by -487.21%, while revenue for the quarter reached $142.38M , missing expectations by -6.72%.
Earnings released on 30 Jun 2021
EPS came in at -$0.23 surpassing the estimated -$0.33 by +30.03%, while revenue for the quarter reached $144.11M , missing expectations by -6.41%.
Earnings released on 30 Dec 2020
EPS came in at -$1.78 falling short of the estimated -$0.05 by -3.18K%, while revenue for the quarter reached $160.16M , missing expectations by -2.02%.
MAYNF Stock Performance
Access detailed MAYNF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.